2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Zabaleta, A, Puig, N, Cedena, MT, Oliver-Caldes, A, Perez, JJ, Moreno, C, Tamariz-Amador, LE, Rodriguez-Otero, P, Prosper, F, Gonzalez-Calle, V, López-Corral, L, Rey-Búa, B, Puertas, B, Mirás, F, Sánchez-Pina, J, López-Muñoz, N, Juan, ME, González-Navarro, E, Urbano, A, de Larrea, C, Blade, J, Lahuerta, JJ, Martinez-Lopez, J, Mateos, MV, San Miguel, JF, Paiva, B. Clinical significance of complete remission and measurable residual disease in relapsed/refractory multiple myeloma patients treated with T-cell redirecting immunotherapy. AM J HEMATOL 100 93-102. 1 ene 2025. 1 nov 2024. . F.I.:10,100 [doi:10.1002/ajh.27526]